NLRC5

NLR family CARD domain containing 5, the group of NLR family

Basic information

Region (hg38): 16:56989485-57083531

Links

ENSG00000140853NCBI:84166OMIM:613537HGNC:29933Uniprot:Q86WI3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NLRC5 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NLRC5 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
5
clinvar
2
clinvar
7
missense
89
clinvar
11
clinvar
2
clinvar
102
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
0
Total 0 0 89 16 4

Variants in NLRC5

This is a list of pathogenic ClinVar variants found in the NLRC5 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-57020544-T-C not provided (-)103154
16-57020726-G-T not specified Uncertain significance (Oct 14, 2021)2255391
16-57020780-A-C not specified Uncertain significance (Aug 02, 2022)2293505
16-57020800-G-A not specified Uncertain significance (Sep 01, 2021)2222026
16-57020828-C-T not specified Likely benign (Mar 31, 2022)3200491
16-57020838-T-G not specified Uncertain significance (Apr 13, 2022)2283585
16-57020848-G-A not specified Uncertain significance (Sep 14, 2022)2371903
16-57020859-C-G not specified Uncertain significance (Apr 24, 2024)3300003
16-57020867-A-G not specified Uncertain significance (Jun 09, 2022)2211671
16-57020990-C-G not specified Uncertain significance (Jun 28, 2022)2298258
16-57022227-A-C not provided (-)103171
16-57023663-C-T not provided (-)103182
16-57023697-G-A not provided (-)103183
16-57023899-C-G not provided (-)103193
16-57024091-C-T not provided (-)103191
16-57024129-C-T not provided (-)103192
16-57025406-G-A not specified Uncertain significance (May 11, 2022)3200509
16-57025419-A-G not specified Uncertain significance (Aug 08, 2023)2616707
16-57025425-G-A not specified Uncertain significance (Oct 26, 2022)2320721
16-57025491-G-A not specified Uncertain significance (Jun 16, 2024)3300010
16-57025493-G-A not specified Uncertain significance (May 26, 2022)2384375
16-57025538-G-A not specified Uncertain significance (Jul 20, 2021)2358804
16-57025539-T-C not specified Uncertain significance (Sep 01, 2021)2222025
16-57025557-C-T not specified Uncertain significance (Sep 13, 2023)2623089
16-57025587-C-G not specified Uncertain significance (Mar 25, 2024)3300002

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NLRC5protein_codingprotein_codingENST00000262510 4794047
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
9.42e-81.001256770711257480.000282
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.018371.02e+30.8230.000058212102
Missense in Polyphen101185.240.545242596
Synonymous0.7484244440.9550.00002683816
Loss of Function5.903090.60.3310.000004301062

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005480.000544
Ashkenazi Jewish0.000.00
East Asian0.0001630.000163
Finnish0.0004360.000416
European (Non-Finnish)0.0003600.000352
Middle Eastern0.0001630.000163
South Asian0.0001640.000163
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable regulator of the NF-kappa-B and type I interferon signaling pathways. May also regulate the type II interferon signaling pathway. Plays a role in homeostatic control of innate immunity and in antiviral defense mechanisms. {ECO:0000269|PubMed:20061403, ECO:0000269|PubMed:20434986}.;
Pathway
DDX58/IFIH1-mediated induction of interferon-alpha/beta;Innate Immune System;Immune System;Negative regulators of DDX58/IFIH1 signaling (Consensus)

Recessive Scores

pRec
0.0897

Intolerance Scores

loftool
rvis_EVS
0.51
rvis_percentile_EVS
80.3

Haploinsufficiency Scores

pHI
0.0793
hipred
N
hipred_score
0.429
ghis
0.474

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.277

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Nlrc5
Phenotype
immune system phenotype; hematopoietic system phenotype;

Gene ontology

Biological process
response to bacterium;negative regulation of NF-kappaB transcription factor activity;negative regulation of type I interferon production;intracellular signal transduction;regulation of kinase activity;innate immune response;positive regulation of MHC class I biosynthetic process;positive regulation of transcription by RNA polymerase II;defense response to virus;positive regulation of interferon-gamma-mediated signaling pathway;negative regulation of type I interferon-mediated signaling pathway;positive regulation of type I interferon-mediated signaling pathway
Cellular component
nucleus;cytoplasm;centrosome;cytosol
Molecular function
RNA polymerase II proximal promoter sequence-specific DNA binding;protein binding;ATP binding